Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision history updated from v3.4.0 to v3.4.1. No study details or other content were modified.
    Difference
    0.0%
    Check dated 2026-02-05T17:29:30.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The label in the Study Record Dates changes from 'Last Update Posted (Estimated)' to 'Last Update Posted', a UI simplification that does not affect data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-22T06:13:25.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4; no substantive changes to the study details or page content were observed.
    Difference
    0.0%
    Check dated 2026-01-15T04:04:54.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    - Consolidated site locations under a single 'Locations' header listing California, Maryland, New Jersey, and Ohio, removing the separate state-specific location subsections.
    Difference
    0.4%
    Check dated 2025-12-23T20:45:21.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Publications section now notes that items are automatically filled from PubMed, and the revision tag has been updated to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T00:31:07.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Removed the government funding/status notice from the page. The core study information, including the title, conditions, eligibility criteria, and study plan, remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T20:09:11.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.